S1. Synthesis of fluorescent mitochondria targeted compound 4:
A suspension of 5-aminonaphthalenesulfonic acid (2.23 g, 10 mmol) and phthalic anhydride (1.55 g, 10.5 mmol) in toluene and pyridine (1:1, 40 mL) was subjected to azeotopic refluxing for 12 h at 130 °C under nitrogen employing a Dean Stark apparatus. Subsequently, the reaction mixture was kept at 4 o C for 3 hours. The obtained precipitate was filtered and washed with toluene, followed by ether. The light gray solid (3.53 g) was then dried under vacuum, and was used in the next step without further purification. 1 H NMR (400 MHz, CDCl3)  7.4-7.52 (m, 1H), 2H), 7 H), 2H), 2H J =8.45Hz), (distorted doublet, 1H, J = 8.3 Hz).
The protected sulfonic acid (2.0 g, 5.66 mmol) was taken into a round bottom flask containing toluene (70 mL). Thionyl chloride (2 mL) was added to the suspension followed by the dropwise addition of DMF (0.4 mL). The suspension was heated at 80 °C overnight under a nitrogen atmosphere. After cooling to room temperature, the precipitate was filtered, and washed with toluene and ether. The obtained solid sulfonyl chloride product (1.51 g, 3.88 mmol, yield: 75%)
was dried under vacuum, and was used in the next step.
The obtained sulfonyl chloride (2 g, 5.06 mmol) was added to dry acetonitrile (60 mL). To this mixture, K2CO3 (781 mg, 5.65 mmol) and catalytic KI (35 mg) were added sequentially followed by addition of mono BOC-protected ethylenediamine (905 mg, 5.65 mmol). The resulting solution was stirred overnight at room temperature. The solvent was removed and the residue was dissolved in dicholomethane, washed with water, aqueous NaOH (0.5 N), and brine. The organic layer was dried over Na2SO4, evaporated under vacuum, and the product was purified by flash chromatography on a silica gel column using 4% methanol in dichloromethane as a solvent (Rf = 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1.14 1. 
S2. Conjugation to PLA-PEG polymer to compound 4:
The polymer PLA-PEG-N3 was reacted with synthesized mitochondria targeting fluorescent compound 4 employing the "Click" reaction. To click the alkyne end of the peptide to the azide end of the lipid, both the compounds were reacted in 1:2 molar ratio taking compound 4 in excess.
Compound 4 (10 mg) and PLA-PEG-N3 (50 mg) were dissolved in 3 mL THF. The copper complex was prepared by mixing copper (II) sulfate (72 mg) with N,N,N',N',N''-pentamethyldiethylenetriamine (PMDETA) (200 µL) in water (3 mL) for 2 hours at room temperature. A solution of ascorbic acid was prepared in water. The copper complex (0.053 µM CuSO4 solution in water and 2 mmol PMDETA stirred for 2 hours) and sodium ascorbate (1.4 µmol) were added to the reaction mixture, and stirred for 24 hours at room temperature. The sample was transferred to a dialysis cassette with molecular cut off of 3,000. The reaction mixture was dialyzed against water for 72 hours to remove the catalyst and unreacted compound 4. The product was then analyzed by fluorescence spectroscopy. 
S4. Preparation of the polymersomes:
The synthesized mitochondria-targeting polymer 5 and PLLA5000-PEG2000 polymer were dissolved in THF to make a stock solution (10mg/mL) for each polymer. From the stock solution, mitochondria-targeting polymer 5 (0.21 mg, 21µL) and PLLA5000-PEG2000 (2 mg, 200µL) were mixed in a separate vial and THF was evaporated. The relative molar ratio for the polymers was 90:10 for all the experiments. This solution was added dropwise to 25 mM HEPES buffer (pH 7.4, 2 mL) in another vial, and the mixture was stirred for 1 h. The THF was evaporated by bubbling air through the solution to encapsulate buffer in the polymersomes. The formed polymersomes were then sonicated for 1 hour in a bath sonicator (Aquasonic 250D, power level 9), and then size was analyzed by dynamic light scattering (DLS). To prepare carboxyfluorescein encapsulated polymersomes were also prepared in the same way where the HEPES buffer (25mM) was substituted with carboxyfluorescein solution (100mM, pH 7). After preparation of polymersomes,
S5. Size analysis of the polymersomes:
The hydrodynamic diameters of polymersomes were measured using a Dynamic Light Scattering (DLS) instrument (Malvern Zetasizer Nano-ZS90). Measurements were conducted at a scattering angle of 90 o using a disposable polystyrene cuvette. An equilibration time of 120 s was maintained for all the measurements. For each sample, 6 readings were recorded averaging 6 runs for the same reading.
S6. Zeta potential analysis:
Zeta potential was measured using a Malvern Zetasizer Nano-ZS90 employing a disposable folded capillary cell (Malvern DTS1070). We recorded 6 readings after averaging 10 runs for each reading. Zeta potential for mitochondria targeted compound was recorded after dissolving 1 mg of the compound in 100 µL of tetrahydrofuran and diluting it with 1 mL with water. The polymersome were prepared in water for zeta potential analysis. We observed positive zeta potential for the mitochondria targeting compound which was reduced after conjugation to PLA-PEG-N3. After formation of the polymersomes, the zeta potential was further reduced to 9 mV (Table 1) . 
S7. Polymersome vesicle imaging:
The dye FM1-43 was used to stain polymersome vesicles.
1 We encapsulated FM1-43 (Biotium) in the polymersome vesicles, and imaged it with a laser scanning confocal microscope (Olympus) equipped with 60X objective. To prepare the dye-encapsulated polymersomes, FM1-43 (100 µg) and polymer 5 (2 mg) were blended together, and dissolved in THF (200 µL). This solution was then added dropwise to 2 mL phosphate buffer (10 mM, pH 7.4). The mixture was stirred for 1 hour at room temperature, and THF was evaporated by passing air through the mixture. The resultant polymersomes were briefly sonicated for 5 minutes using a bath sonicator (Aquasonic Model 250D, level 9). The polymersomes were passed through a Sephadex G100 gel filtration column to remove the unencapsulated dye. These large polymersomes were them imaged using a confocal microscope (60X objective) We observed the dye encapsulated in the bilayer of the large polymersome vesicles ( Figure S7 ). 
S8. Isolation of mitochondria from the pancreatic cancer cells:
The pancreatic cancer cell line BxPC-3 was purchased from American Type Culture Collection (Manassas, VA). The BxPC-3 cells were cultured in RPMI media (Hyclone) supplemented with 10% fetal bovine serum (Gibco) and 2% antibiotics (Corning). The cells were grown at 37 ºC in a humidified atmosphere containing 5% CO2. Mitochondria were isolated from the BxPC-3 cells following manufacturer's (Focus Mitochondria, G Biosciences) protocol for 'isolation of mitochondria from animal cells'
(http://www.gbiosciences.com/PDF/Protocol/FOCUS_Mitochondria.pdf). Briefly, the BxPC-3 cells suspended in RPMI media after trypsinization were pelleted by centrifugation at 800 g for 1 minute and the supernatant was discarded. To this pellet, 500 µL of ice-cold the supplied SubCell
Buffer-I was added to suspend the cells in the buffer. The cells were transferred to a microcentrifuge tube and were incubated on ice for 10 minutes. The cells were then lysed on ice by using a narrow opening (23 gauge) syringe needle. The supplied 3X SubCell Buffer-II (250 µL) was added to the lysed cells and mixed. The cells were again centrifuged at 700 g for 10 minutes to pellet the nuclei. The supernatant was transferred to a new tube and centrifuged at 12,000 g for 15 minutes to obtain a pellet of mitochondria.
S9. TEM imaging of the isolated mitochondria:
Mitochondria were isolated from BxPC-3 Cells after 2 hours of treatment with the targeted polymersomes. Non-treated BxPC-3 cells were used as control. Mitochondria specimens for transmission electron microscopy were fixed in 2.5% glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.35 (Tousimis Research Corporation, Rockville MD) for at least two hours in the refrigerator. They were rinsed twice in sodium phosphate buffer and then placed in 2% osmium tetroxide in buffer for two hours at room temperature. Following buffer rinse, water rinse, and dehydration in a graded acetone series, samples were embedded in Epon-Araldite-DDSA with DMP-30 accelerator and sectioned at 50-70 nm thickness on a RMC MT XL ultramicrotome (Boeckeler Instruments, Tucson AZ). Prior to each solvent change, the samples were centrifuged.
Sections on copper grids were stained with lead citrate for 2.5 minutes and dried before being observed and photographed on a JEOL JEM-100CX II electron microscope (JEOL Inc., Peabody MA.).
S10. Encapsulation of doxorubicin in the polymersomes:
Polymers were mixed (2.21 mg) in a vial and dissolved in THF (200 µL). This mixture was then added dropwise to 2 mL citrate buffer (220 mM, pH 4) under continuous stirring. After 1 hour of stirring, THF was evaporated for 45 minutes by bubbling air through the mixture. The resulting solution was sonicated in a bath sonicator (Aquasonic 250D, Power level 9) for 45 minutes. To this solution, sodium bicarbonate was added to neutralize the pH of solution outside the polymersomes. An aqueous solution (1mg/mL) of doxorubicin HCl (0.2 mg) was added to the polymersome solution and the mixture was stirred for 6 hours at room temperature. A Sephadex G100 gel filtration column was saturated with iso-osmolar HEPES buffer (25 mM, pH 7.4), and polymersomes were passed through the column to remove the unencapsulated doxorubicin. The polymersomes collected were then analyzed for entrapment efficiency.
S11. Mitochondrial uptake imaging:
The pancreatic cancer cell line BxPC-3 was purchased from American Type Culture Collection and TRITC filter for visualizing the mitochondria. In a similar way, the cells were treated for 30 minutes, 1 hour, 2 hours, and 4 hours, and then imaged. The images were analyzed by using the software ImageJ for calculating percent overlap in the fluorescence and determining mitochondrial uptake.
